Taurean Brown
Researcher
Also affiliated: University of Southern California (2005)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Taurean Brown's research investigates the neurological and physiological impacts of chemotherapy, particularly focusing on chemotherapy-induced cognitive impairment. Brown has published work examining the implications of breast cancer chemotherapy on various bodily systems, including the gut, liver, and central nervous system. This work also explores specific chemotherapeutic agents, such as docetaxel, doxorubicin, and cyclophosphamide, in relation to cognitive dysfunction. A recent publication highlights the potential of piperlongumine as a neuro-protectant agent to mitigate these cognitive side effects. Brown's research also includes methodologies for dissociating mouse brain hippocampal tissue for experimental analysis. Brown has an h-index of 5 with 153 total citations across 12 publications. Key collaborators include Antiño R. Allen, Pilar Simmons, Fabio Ntagwabira, and Taylor McElroy, all from the University of Arkansas for Medical Sciences, with whom Brown has co-authored multiple publications.
Metrics
- h-index: 5
- Publications: 12
- Citations: 148
Selected Publications
-
Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment (2022)
-
Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue (2021)
-
Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue (2021)
-
Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide (2021)
-
Implications of Breast Cancer Chemotherapy-Induced Inflammation on the Gut, Liver, and Central Nervous System (2021)
-
Cranial irradiation impairs juvenile social memory and modulates hippocampal physiology (2020)
-
Assessing the Effects of Redox Modifier MnTnBuOE-2-PyP 5+ on Cognition and Hippocampal Physiology Following Doxorubicin, Cyclophosphamide, and Paclitaxel Treatment (2020)
Collaboration Network
Top Collaborators
- Implications of Breast Cancer Chemotherapy-Induced Inflammation on the Gut, Liver, and Central Nervous System
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Implications of Breast Cancer Chemotherapy-Induced Inflammation on the Gut, Liver, and Central Nervous System
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
Similar Researchers
Based on overlapping research topics